Huntsville Company Develops SARS-CoV-2 Test
Huntsville-based Diatherix Eurofins has developed a test for the SARS-CoV-2 virus, the cause of the COVID-19 respiratory infection, as part of its proprietary respiratory testing...
A Business View of COVID-19 from Blue Cross CEO
An interview with Tim Vines, president and CEO of Blue Cross and Blue Shield of Alabama
UAB COVID Drug Potent for Gilead without “Orphan” Status
A University of Alabama at Birmingham-researched drug with potential for treating COVID-19 recently received FDA approval as a rare disease treatment, a distinction that...
Assurance Ramps Up Testing of COVID-19
Birmingham is home to one of only 26 commercial labs in the nation approved to test for COVID-19.
Assurance Scientific Laboratories is a complex R&D...
Birmingham YMCA Helps Hospital Workers
As the coronavirus spreads in the U.S. and in Alabama, healthcare workers are under tremendous strain to help the sick, while keeping themselves and...
Top COVID-19 Issues Business Clients Ask Attorneys
What business clients are asking their attorney about COVID-19: How to protect their employees, how to handle business disruptions and how to address contractual obligations
New Leadership for SSI Group
The SSI Group, a health care financial technology company based in Mobile, has named Diana Allen its new president and chief executive officer.
Allen most...
Human Testing of New Anticancer Therapy Opens at UAB
Incysus Therapeutics Inc. has received permission to begin testing a new cancer treatment in patients at the University of Alabama at Birmingham.
The new drug-resistant...
“Consultologists,” Costs and Length of Hospital Stays
The sicker you are, the longer your stay in the hospital and the more specialists you see.
That seems logical.
But the correlation between your health...
Reprogrammed Peptides Kill Cancer in Animal Tests
Researchers at Tuskegee University are reprogramming immune cells to kill cancer and halt tumor growth.
Cancerous tumors evade detection and boost their own growth by...
